David Horowitz > Hogan Lovells US LLP > Washington DC, United States > Lawyer Profile
Hogan Lovells US LLP Offices
COLUMBIA SQUARE
555 THIRTEENTH STREET, NW
WASHINGTON DC 20004
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
David Horowitz
Work Department
Pharmaceuticals and Biotechnology
Position
Partner
Career
After 25 years in senior legal and policy positions at the U.S. Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS), including HHS Deputy General Counsel and FDA Director of Drug Compliance, David Horowitz achieves results for clients by helping them anticipate, communicate, and work effectively with regulators and policy makers.
He represents life sciences clients on FDA compliance and regulatory policy issues, including responding to FDA warnings and compliance actions, import and export issues, current good manufacturing practice (GMP) requirements, drug shortages, registration/listing, pharmacy/compounding issues, Over-the-Counter (OTC) drugs, and user fees. His insight into FDA’s requirements, statements, and actions allows him to identify solutions that satisfy the clients’ business needs within FDA’s regulatory framework.
Prior to joining Hogan Lovells, he served as Deputy General Counsel at HHS, advising the Secretary of HHS on FDA issues and overseeing the lawyers at FDA, CDC and NIH. Before this role, he worked for over 17 years in senior legal and compliance positions at FDA, including as Director of Compliance for the Center for Drug Evaluation and Research (CDER), Assistant Commissioner for Policy, and Associate Chief Counsel for Drugs.
Languages
English
Education
J.D., University of Virginia School of Law; B.A., Brown University, magna cum laude
Top Tier Firm Rankings
- Transport > Aviation and air travel: litigation and regulation
- Antitrust > Cartel
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Industry focus > Education
- Government > Government relations
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Transport > Rail and road: litigation and regulation
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- International Trade > Trade remedies and trade policy
Firm Rankings
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- International Trade > CFIUS
- International Trade > Customs, export controls and economic sanctions
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy regulation: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Government > Government contracts
- Healthcare > Health insurers
- Healthcare > Life sciences
- Healthcare > Service providers
- Tax > US taxes: non-contentious
- Insurance > Advice to insurers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Energy > Energy regulation: electric power
- Finance > Fintech
- Labor and employment > Immigration
- Dispute resolution > International litigation
- Tax > International tax
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- M&A/corporate and commercial > Shareholder activism
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy litigation: oil and gas
- Finance > Project finance
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Finance > Project finance
- Dispute resolution > International arbitration
- Finance > Financial services regulation
- Investment fund formation and management > Private equity funds (including venture capital)